Tag: The Lancet Child and Adolescent Health

Lactobacillus rhamnosus

Enrollment Complete for Phase 2b Probiotic Oral Immunotherapy Treatment Candidate

Study to provide evidence of longer lasting tolerance to peanut in a larger number of patients.